Cantor Fitzgerald Reiterates Overweight Rating on Humanigen (HGEN), Expects Upward Earnings Revisions

March 1, 2022 6:54 AM EST Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $30.00 price target on Humanigen (NASDAQ: HGEN), following the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login